Monografie
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
- Sprache
-
Englisch
- Identifier
-
1277530033
- Beteiligte Personen und Organisationen
- DOI
-
10.1159/000519108
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
02.05.2023, 09:12 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Fessas, Petros
- Naeem, Muntaha
- Bettinger, Dominik
- Cortellini, Alessio
- Pinato, David James
Ähnliche Objekte (12)
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
T cell Re-direction against Glypican-3 for Immunotherapy of Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Predisposition to apoptosis in hepatocellular carcinoma: from mechanistic insights to therapeutic strategies
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
RIG-I-based immunotherapy of hepatocellular carcinoma : target validation and mechanisms of action in vivo
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
T cell Re-direction against Glypican-3 for Immunotherapy of Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Predisposition to apoptosis in hepatocellular carcinoma: from mechanistic insights to therapeutic strategies
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
RIG-I-based immunotherapy of hepatocellular carcinoma : target validation and mechanisms of action in vivo
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
T cell Re-direction against Glypican-3 for Immunotherapy of Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Predisposition to apoptosis in hepatocellular carcinoma: from mechanistic insights to therapeutic strategies
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach